Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Net Cash Flow (2024 - 2025)

Carlsmed's Net Cash Flow history spans 2 years, with the latest figure at -$29.6 million for Q4 2025.

  • For Q4 2025, Net Cash Flow fell 585.52% year-over-year to -$29.6 million; the TTM value through Dec 2025 reached $48.0 million, changed N/A, while the annual FY2025 figure was $45.7 million, 39.01% up from the prior year.
  • Net Cash Flow reached -$29.6 million in Q4 2025 per CARL's latest filing, down from $81.9 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $81.9 million in Q3 2025 to a low of -$29.6 million in Q4 2025.